disease

Metabolic Syndrome

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Metabolic Syndrome: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

723Connections

0Hypotheses

0Analyses

50Outgoing

50Incoming

Summary

Metabolic Syndrome is a disease characterized by neurodegeneration research. Key relationships include: activates, associated with, therapeutic target. Associated with Aging, Als, Alzheimer. Connected to 523 entities in the SciDEX knowledge graph.

View on Wiki →

Disease Info

Associated Genes	RUBCN, TREM2, ACTB, ATG, CAT, CTSD, EGFR, EIF4EBP1
KG Connections	689 knowledge graph edges
Databases	OMIM Orphanet ClinicalTrials PubMed

Wiki Pages (20)

Knowledge base pages for this entity

Pathway Diagram

graph TD
    Metabolic_Syndrome["Metabolic Syndrome"] -->|"activates"| Lipid_Metabolism["Lipid Metabolism"]
    Metabolic_Syndrome["Metabolic Syndrome"] -->|"activates"| Mtor["Mtor"]
    Metabolic_Syndrome["Metabolic Syndrome"] -->|"activates"| Lysosomal_Degradation["Lysosomal Degradation"]
    Metabolic_Syndrome["Metabolic Syndrome"] -->|"activates"| Autophagy["Autophagy"]
    Metabolic_Syndrome["Metabolic Syndrome"] -->|"regulates"| Lipid_Metabolism_1["Lipid Metabolism"]
    Metabolic_Syndrome["Metabolic Syndrome"] -->|"therapeutic target"| Epigenetic["Epigenetic"]
    Circadian_Disruption["Circadian Disruption"] -->|"risk factor for"| Metabolic_Syndrome["Metabolic Syndrome"]
    ACTB["ACTB"] -->|"activates"| Metabolic_Syndrome["Metabolic Syndrome"]
    PPARA["PPARA"] -->|"activates"| Metabolic_Syndrome["Metabolic Syndrome"]
    CAT["CAT"] -->|"activates"| Metabolic_Syndrome["Metabolic Syndrome"]
    style Metabolic_Syndrome fill:#ef5350,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0

Outgoing (216)

Target	Relation	Type	Str
Insulin Resistance	associated_with	disease	1.00
Obesity	associated_with	disease	1.00
Lipid Metabolism	activates	pathway	1.00
Type 2 Diabetes	associated_with	disease	0.95
Als	associated_with	disease	0.95
Non-Alcoholic Fatty Liver Disease	risk_factor_for	disease	0.90
Lipid Metabolism	regulates	pathway	0.90
Inflammation	activates	disease	0.85
Insulin Resistance	activates	disease	0.85
Als	therapeutic_target	disease	0.85
Inflammation	therapeutic_target	disease	0.85
Als	regulates	disease	0.85
Obesity	regulates	disease	0.85
Oxidative Stress	activates	pathway	0.80
Glycolysis	activates	pathway	0.80
Pi3K/Akt	activates	pathway	0.80
Oxidative Stress	regulates	pathway	0.75
Inflammation	contributes_to	disease	0.75
Fatty Liver	activates	disease	0.75
Inflammation	regulates	disease	0.75
Fatty Liver	regulates	disease	0.75
Hepatitis	associated_with	disease	0.75
Atherosclerosis	regulates	disease	0.75
Mtor	activates	pathway	0.70
Autophagy	activates	pathway	0.70
Tgf-Β	therapeutic_target	pathway	0.70
Immune Response	regulates	pathway	0.70
Oxidative Stress	contributes_to	pathway	0.70
Cholesterol	associated_with	pathway	0.70
Cholesterol	activates	pathway	0.70
Mtor	therapeutic_target	pathway	0.70
Oxidative Stress	associated_with	pathway	0.70
Cholesterol	regulates	pathway	0.70
Microrna	regulates	pathway	0.70
Oxidative Stress	treats	pathway	0.70
Oxidative Stress	therapeutic_target	pathway	0.70
Autophagy	associated_with	pathway	0.65
Insulin Signaling	activates	pathway	0.65
Als	activates	disease	0.65
Obesity	activates	disease	0.65
Type 2 Diabetes	activates	disease	0.65
Insulin Resistance	causes	disease	0.65
Inflammation	associated_with	disease	0.65
Type 2 Diabetes	regulates	disease	0.65
Als	implicated_in	disease	0.65
Atherosclerosis	causes	disease	0.65
Inflammation	causes	disease	0.65
Nafld	contributes_to	disease	0.65
Insulin Resistance	regulates	disease	0.65
Lysosomal Degradation	activates	pathway	0.60

Incoming (507)

Source	Relation	Type	Str
Diabetes	associated_with	disease	1.00
Cardiovascular	associated_with	disease	1.00
Hypertension	associated_with	disease	1.00
AMPK	therapeutic_target	gene	1.00
CANCER	therapeutic_target	gene	1.00
INSULIN RESISTANCE	activates	gene	1.00
CANCER	activates	gene	1.00
INSULIN RESISTANCE	associated_with	gene	1.00
PI3K	activates	gene	0.95
AKT	activates	gene	0.95
INFLAMMATION	regulates	gene	0.95
INFLAMMATION	activates	gene	0.95
Cancer	therapeutic_target	disease	0.95
Insulin Resistance	associated_with	phenotype	0.90
Mitochondrial Dysfunction	associated_with	process	0.90
Mitochondrial Dysfunction	contributes_to	process	0.90
Insomnia	risk_factor_for	disease	0.90
SQSTM1	activates	gene	0.85
GENES	regulates	gene	0.85
GENES	activates	gene	0.85
INFLAMMATION	therapeutic_target	gene	0.85
OXIDATIVE STRESS	activates	gene	0.85
ATP	activates	gene	0.85
DIABETES MELLITUS	associated_with	gene	0.85
OXIDATIVE STRESS	regulates	gene	0.85
Circadian Disruption	risk_factor_for	process	0.85
OXIDATIVE STRESS	associated_with	gene	0.85
Obesity	activates	disease	0.85
Cancer	activates	disease	0.85
Tumor	activates	disease	0.85
Diabetes	activates	disease	0.85
DIABETES MELLITUS	activates	gene	0.85
INFLAMMATION	contributes_to	gene	0.85
MITOCHONDRIA	implicated_in	gene	0.85
IL-6	causes	gene	0.85
Tumor	therapeutic_target	disease	0.85
Diabetes	regulates	disease	0.85
Cardiovascular	regulates	disease	0.85
MITOCHONDRIA	regulates	gene	0.85
IL-6	activates	gene	0.85
Rubcn Deficiency	associated_with	phenotype	0.85
Circadian Clock Pathway	therapeutic_target	pathway	0.85
circadian rhythm disruption	risk_factor_for	process	0.85
circadian clock	regulates	pathway	0.85
PTP1B	protects_against	gene	0.80
Clock Gene Expression	contributes_to	process	0.80
Circadian Disruption	contributes_to	process	0.80
MYC	activates	gene	0.75
MTOR	activates	gene	0.75
Als	associated_with	disease	0.75

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
No targeting hypotheses

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Metabolic Syndrome

Understanding Entity Pages

Summary

Wiki Pages (20)

cbs-psp-daily-action-plan

TREM2 Mechanism Hub

APOC4 — Apolipoprotein C-IV

Pre-symptomatic Conversion Windows in ALS Genetic Risk Carriers

rapamycin-tauopathy

Metabolomic Alterations in PSP

Cerebral Small Vessel Disease

Baylor College of Medicine

Synaptic Plasticity Deficits in Neurodegeneration

Gut-Microbiome-Neurodegeneration Axis

Wallerian Degeneration

Melanotrophs

Advanced Glycation End Products in Neurodegeneration

Type 3 Diabetes Hypothesis of Alzheimer's Disease

GPT - Alanine Transaminase (ALT)

AD Therapeutic Approaches Ranked Scorecard

BDNF/Neurotrophin Signaling in Neurodegeneration

Glucocorticoid Signaling Pathway in Neurodegeneration